Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Hypogonadism is a clinical condition that can be associated with obesity in man. Controversy
exists regarding if its a condition that needs to be treated. The standard Testosterone
Therapy is associated with increase in cardiovascular risks, according to some studies, and
leads to infertility. The use of Clomiphene Citrate in this sub population of obese man as an
alternative treatment option is not well studied. The aim of this protocol is to evaluate the
cardiovascular risks, metabolic and hormonal parameters in a double blinded randomized
placebo trial.
Phase:
Phase 2
Details
Lead Sponsor:
University of Sao Paulo
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo